 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||| REGN6490 / Regeneron
Trial termination: Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers (clinicaltrials.gov) - Nov 10, 2021
P1, N=57, Terminated, Sponsor: Regeneron Pharmaceuticals
Active, not recruiting --> Terminated; Sponsor decision
- REGN6490 / Regeneron
Enrollment change, Trial termination: Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers (clinicaltrials.gov) - Nov 10, 2021
P1, N=19, Terminated, Sponsor: Regeneron Pharmaceuticals
Active, not recruiting --> Terminated; Sponsor decision N=32 --> 19 | Recruiting --> Terminated; Sponsor decision
- || REGN6490 / Regeneron
Enrollment closed: Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers (clinicaltrials.gov) - Apr 20, 2021
P1, N=64, Active, not recruiting, Sponsor: Regeneron Pharmaceuticals
N=32 --> 19 | Recruiting --> Terminated; Sponsor decision Recruiting --> Active, not recruiting
- ||| REGN6490 / Regeneron
Enrollment open: Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers (clinicaltrials.gov) - Feb 11, 2021
P1, N=64, Recruiting, Sponsor: Regeneron Pharmaceuticals
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || REGN6490 / Regeneron
Enrollment open: Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers (clinicaltrials.gov) - Feb 8, 2021
P1, N=32, Recruiting, Sponsor: Regeneron Pharmaceuticals
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| REGN6490 / Regeneron
New P1 trial: Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers (clinicaltrials.gov) - Nov 3, 2020
P1, N=64, Not yet recruiting, Sponsor: Regeneron Pharmaceuticals
- || REGN6490 / Regeneron
New P1 trial: Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers (clinicaltrials.gov) - Nov 3, 2020
P1, N=32, Not yet recruiting, Sponsor: Regeneron Pharmaceuticals